Please wait
Healthcare · Medical Devices · Price, fundamentals, signals, and forward-looking context in one research view.
Healthcare
$10.4B
N/A
47.17
Current price
$385.24
-0.6% todayUpdated just now
Open
$390.82
Previous close
$387.70
Day range
$382.10 – $394.02
Volume
N/A
47.2x P/E
Awaiting filing
No current yield
65/100 measured
Easy to trade
Recent price movement, key market context and the latest company information.
The latest saved price history for BIO, with its range and direction at a glance.
Bio-Rad Laboratories, Inc. develops, manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, Latin America, and internationally. It operates through two segments, Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantify biological materials, including cells, proteins, and nucleic acids used in research and biopharmaceutical laboratory environments, as well as for biopharmaceutical manufacturing, quality control process, food safety, and science education applications. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology companies, food producers, and testing laboratories. Its Clinical Diagnostics segment designs, manufactures, markets, and supports diagnostic test systems, informatics systems, test kits, and specialized quality controls for clinical, hospital, diagnostic reference, and transfusion and physician office laboratories, as well as software. The company offers its products through its direct commercial organization, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.
Investors usually follow BIO for its valuation signal, sector position, and upcoming company events. The goal here is not just to show numbers, but to explain what they mean in plain English.
Whisone is bullish because fundamentals are solid at 66/100 while there is no strong bear warning from the current data. Whisone has moderate conviction here. The final read is being balanced by the weighted scores for fundamentals, technicals, insider flow, sentiment, event flow, and liquidity.
Whisone v2 splits the read into weighted parts so the score is not just one hidden number.
Fundamentals
Growth, margins, cash flow, and valuation.
Latest net profit
$371M
TTM (2026-06-30)
ROE
3.1%
Return on equity
ROA
1.7%
Return on assets
Debt / equity
0.19
Lower is usually safer.
P/B ratio
1.45
Useful for book value support.
85/100
Direction
Range-bound
Main supports
Recent price behavior and momentum still support follow-through.
Recent price and fundamentals refreshes improve signal reliability.
What can go wrong
Volatility is elevated, so the path can stay rough even if the thesis is right.
Analyst target data does not currently point to clear upside.
Fair value
$358.35
Analyst view
None
Analyst target
$329.00
Forecast refresh
Updated 10h ago
Quality score
66
Growth score
50
These are the external analyst numbers and business outlook figures already synced into the company record.
No external analyst outlook is available for this company yet.
A plain-English reading of momentum, trend, volatility, range position, and trading participation.
RSI
N/A
Momentum data is not available yet.
Recent trend
Rising
+18.4% across the latest saved price window.
Volatility
Moderate
Beta is 1.05. Price sensitivity is broadly around the market range.
52-week position
93% of range
Price is trading close to its 52-week high.
Volume confirmation
N/A
Comparable volume data is not available.
P/E: 47.16545
Yield: N/A
ABBV
AbbVie Inc.
Price: $256.22
P/E: 72.994286
Yield: 2.7%
ABT
Abbott Laboratories
Price: $110.02
P/E: 36.39806
Yield: 2.3%
ALGN
Align Technology, Inc.
Price: $158.16
P/E: 27.310226
Yield: 0.0%
Industry
Medical Devices
Employees
7450
Exchange
NYQ
Ticker
BIO
